Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis

MeSH terms

• Aged
• Antirheumatic Agents / administration & dosage*
• Antirheumatic Agents / adverse effects
• Arthritis / diagnosis
• Arthritis / drug therapy*
• Arthritis / immunology
• Biological Products / administration & dosage*
• Biological Products / adverse effects
• Biosimilar Pharmaceuticals / administration & dosage*
• Biosimilar Pharmaceuticals / adverse effects
• Databases, Factual
• Drug Substitution*
• Female
• Humans
• Infliximab / administration & dosage*
• Infliximab / adverse effects
• Male
• Middle Aged
• Retrospective Studies
• Time Factors
• Treatment Outcome